https://www.businessweekly.com.tw/focus/blog/3007006
https://www.businessweekly.com.tw/focus/blog/3007006?utm_source=Line&utm_medium=social&utm_content=bw&utm_campaign=content

權威期刊《自然》:輝瑞、莫德納等mRNA疫苗,保護力達終身!前提是⋯-中央社|商周

1.最新研究顯示,由輝瑞、莫德納開發的mRNA疫苗,能引發人體持續性的免疫反應,有機會提供長達數年的保護力,甚至終身。2.這意味,接種mRNA疫苗的多數人可能不需施打追加劑量。但,前提是新冠病毒未來的

https://www.businessweekly.com.tw/focus/blog/3007006

權威期刊《自然》:輝瑞、莫德納等mRNA疫苗,保護力達終身!前提是⋯-中央社|商周

1.最新研究顯示,由輝瑞、莫德納開發的mRNA疫苗,能引發人體持續性的免疫反應,有機會提供長達數年的保護力,甚至終身。2.這意味,接種mRNA疫苗的多數人可能不需施打追加劑量。但,前提是新冠病毒未來的

https://www.businessweekly.com.tw/focus/blog/3007006?utm_source=Line&utm_medium=social&utm_content=bw&utm_campaign=content
Past 31 days
Total Visit: 0
There is 1 fact-checking reply to the message
Lin mark this message contains misinformation
originally written by Lin
沒有疫苗可永久提供100%保護力,特別是當特定變異株流行導致疫苗保護力下降時,因此在完整接種COVID-19疫苗後發生突破性感染是可預期的,雖然發生比例極低,但發生率可能隨疫苗接種後時間增加而上升。隨著疫苗涵蓋率增加,確診個案中為完整接種疫苗的佔比,也可能會增加,即便如此,COVID-19疫苗仍可以有效預防住院、重症及死亡的發生。

References

https://www.cdc.gov.tw/EpidemicTheme/Detail/HN_bvfRk6F9P3-V-G4NJxQ?archiveId=k4nd15up8aeJWFIpzM1Luw

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙